FindMyKOL
✓ Itemized record
RegionSan Antonio, TX · South CentralSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Randall Bell is a Respiratory physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 7 publications with 949 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
7publications

Publications indexed by OpenAlex. Counts exclude supporting files.

949citations

Citations across these publications.

7h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
44companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • AstraZeneca Pharmaceuticals LP
    Program year202534 payments
    $656
  • GlaxoSmithKline, LLC.
    Program year202531 payments
    $567
  • Regeneron Healthcare Solutions, Inc.
    Program year202512 payments
    $332
All 106 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    52.6%
    Corticosteroid26.9%
    Trelegy Ellipta38%Symbicort20%Breztri Aerosphere20%Breo Ellipta14%Fluticasone Propionate6%Fluticasone-Vilanterol2%
    Part D<11 patients
    Leukotriene Receptor Antagonist13%
    Montelukast Sodium97%Zafirlukast3%
    Part D<11 patients

    + 3 more classes in this area

  • Sensory organs

    19.1%
    Corticosteroid19.1%
    Dexamethasone sodium phosphate100%
    Part B, office-administered≥89 patients
  • Metabolism & gastrointestinal

    10.5%
    Corticosteroid9.7%
    Prednisone100%
    Part D≥136 patients
    Anticholinergic0.4%
    Scopolamine100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)44.9% facility · 55.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”